Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine of once identified to the subjects infected with human immunodeficiency virus (positive VIH), to diagnose latent Tuberculosis, and to treat her with isoniazid...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Instituto Nacional de Salud Publica, Mexico
Collaborators
NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation
NCT07071623 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
NCT06272812 · Tuberculosis (TB)
NCT04375800 · Human Immunodeficiency Virus (HIV) Infection
NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more
Instituto Nacional de Salud Publica
México, Cuernavaca Morelos
Clínica Especializada CONDESA
Mexico City, D.F
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions